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Prosthetic cardiac valve replacement
To the Editor:
The US Food and Drug Administration
(FDA) has become aware of a problem
associated with cardiac valve prosthetic re-
placement arising from mismatch between
annulus sizing devices and the labeled di-
mension of prostheses. Anecdotal reports
suggest that discrepancies between the la-
beled size of prostheses and the dimensions
of the specific sizer may have compro-
mised seating of selected valve prosthe-
ses.1 Christakis and colleagues2 docu-
mented discrepancies of as much as 8 mm
between the labeled size of a particular
prosthesis and the external diameter of the
sewing cuff. Considerable variation was
also found between the diameters of sew-
ing cuffs for valves labeled as similar in
size by different manufacturers. Although
these discrepancies may not in themselves
be relevant to the implantation procedure
when the appropriately matched device-
specific sizer is used, the use of generic or
so-called universal sizers or of sizers de-
signed for other prostheses, even if from
the same manufacturer, may result in se-
lection of an oversized valve. At best such
an occurrence will require discarding a de-
vice before suture attachment because of
body fluid contamination. A more serious
consequence occurs when the mismatch is
not recognized until the attempt to seat the
prosthesis after suture placement.
To assess the pervasiveness of this
problem with valve sizers, the Society of
Thoracic Surgeons, in cooperation with the
FDA, surveyed a cohort of 200 cardiac
surgeons. One hundred six responders to a
mailed questionnaire identified problems
with manufacturer-supplied sizers in 31 in-
stances and with universal sizers in 7 cases.
The responders also indicated knowledge
of similar problems experienced by other
surgeons in 52 instances.
The intention of this communication is
to alert surgeons to the FDA’s concerns
regarding the problem of valve and sizer
mismatch. The frequency of occurrence
suggests a need for remedial prosthetic la-
beling that accurately and uniformly across
devices describes both sewing cuff external
dimensions and orifice area. Tight manu-
facturing controls should ensure that the
prosthetic sewing cuff dimension matches
the labeled size within specified tolerances
that provide confidence that they are accu-
rately reflected by the sizers used to mea-
sure the cardiac valve annulus.
Because of the FDA’s concerns, sur-
geons are cautioned to use only sizers la-
beled for use with the specific prosthetic
valve to be implanted. In addition, it is
advised that selection of a satisfactory de-
vice fit be confirmed by testing the pros-
thesis within the annulus before insertion
of sewing cuff sutures.
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Resection of pulmonary
arteriovenous fistula
To the Editor:
The article on pulmonary arteriovenous fis-
tula by Schro¨der and colleagues1 was of
interest to me, as was the follow-up Letter
to the Editor by Fell.2
I have treated a number of patients with
pulmonary arteriovenous fistulas through
the years, including in particular a family
congenitally affected for 4 generations. Ini-
tially, in the early 1970s, I performed pri-
mary resection of the fistulous lesions with-
out removal of additional lung tissue.
The Editor welcomes submissions for
possible publication in the Letters to the
Editor section that consist of commen-
tary on an article published in the Jour-
nal or other relevant issues. Authors
should:
● Include no more than 500 words of text,
three authors, and five references
● Type with double-spacing
● See http://jtcs.ctsnetjournals.org/misc/
ifora.shtml for detailed submission
instructions.
● Submit the letter electronically via
jtcvs.editorialmanager.com.
Letters commenting on an article pub-
lished in the JTCVS will be considered if
they are received within 6 weeks of the
time the article was published. Authors
of the article being commented on will be
given an opportunity to offer a timely
response (2 weeks) to the letter. Authors
of letters will be notified that the letter
has been received. Unpublished letters
cannot be returned.
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